- Home
- AXTA vs ROIV Comparison
AXTA vs ROIV Comparison
Compare AXTA & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTA
- ROIV
- Stock Information
- Founded
- AXTA 1910
- ROIV 2014
- Country
- AXTA United States
- ROIV United Kingdom
- Employees
- AXTA N/A
- ROIV N/A
- Industry
- AXTA Paints/Coatings
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- AXTA Consumer Discretionary
- ROIV Health Care
- Exchange
- AXTA Nasdaq
- ROIV Nasdaq
- Market Cap
- AXTA 8.9B
- ROIV 8.8B
- IPO Year
- AXTA 2014
- ROIV N/A
- Fundamental
- Price
- AXTA $35.99
- ROIV $12.10
- Analyst Decision
- AXTA Buy
- ROIV Strong Buy
- Analyst Count
- AXTA 12
- ROIV 8
- Target Price
- AXTA $42.45
- ROIV $17.93
- AVG Volume (30 Days)
- AXTA 1.5M
- ROIV 4.6M
- Earning Date
- AXTA 02-06-2025
- ROIV 02-11-2025
- Dividend Yield
- AXTA N/A
- ROIV N/A
- EPS Growth
- AXTA 39.14
- ROIV N/A
- EPS
- AXTA 1.49
- ROIV 5.89
- Revenue
- AXTA $5,262,100,000.00
- ROIV $129,128,999.00
- Revenue This Year
- AXTA $3.89
- ROIV $15.98
- Revenue Next Year
- AXTA $2.95
- ROIV N/A
- P/E Ratio
- AXTA $25.33
- ROIV $2.06
- Revenue Growth
- AXTA 2.70
- ROIV 145.68
- 52 Week Low
- AXTA $30.40
- ROIV $9.69
- 52 Week High
- AXTA $41.66
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- AXTA 28.75
- ROIV 52.23
- Support Level
- AXTA $39.60
- ROIV $11.72
- Resistance Level
- AXTA $40.49
- ROIV $12.43
- Average True Range (ATR)
- AXTA 0.67
- ROIV 0.27
- MACD
- AXTA -0.54
- ROIV -0.03
- Stochastic Oscillator
- AXTA 6.94
- ROIV 37.10
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific and Latin America.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.